BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Addex Therapeutics 

12, Chemin Des Aulx
1228 Plan-les-Ouates
Geneva      Switzerland
Phone: 41-22-884-1555 Fax: 41-22-884-1556


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Pharmaceutical

Segment
Pharmaceuticals





 Company News
Addex Therapeutics (ADXN.SW) Amends mGlu2PAM Collaboration Agreement And Receives USD757,000 12/17/2014 9:43:18 AM
Addex Therapeutics (ADXN.SW) And The Charcot-Marie-Tooth Association Enter Collaboration To Advance ADX71441 In Charcot-Marie-Tooth 1A Disorder 10/21/2014 9:13:25 AM
Addex Therapeutics (ADXN.SW) Reports First Half 2014 Financial Results 9/30/2014 9:01:48 AM
Addex Therapeutics (ADXN.SW) ADX71441 Positive Results In Preclinical Model Of Nicotine Addiction 7/10/2014 6:06:33 AM
Addex Therapeutics (ADXN.SW) Shareholders Approve All Board Proposals At Annual General Meeting 6/30/2014 8:53:27 AM
Addex Therapeutics (ADXN.SW) Publishes Annual General Meeting Agenda 6/12/2014 2:05:54 PM
Addex Therapeutics (ADXN.SW)-Janssen Pharmaceutical Inc. Team's Depression Drug Fails In Phase 2a Trial 2/10/2014 7:32:27 AM
Addex Therapeutics (ADXN.SW) and National Institute on Drug Abuse (NIDA) Enter Collaboration to Advance ADX71441 & ADX88178 in Drug Abuse and Addiction 11/4/2013 9:39:09 AM
Addex Therapeutics (ADXN.SW) Licensee Completes Enrollment of 120 Patients in a Phase 2 Clinical Trial of ADX71149 for the Treatment of Anxious Depression 10/29/2013 9:30:12 AM
Addex Therapeutics (ADXN.SW) ADX71441 Dose Dependently Reduced PMP22 Expression Comparable to Baclofen in a Pre-Clinical Transgenic Model of Charcot-Marie-Tooth 1A Disease 10/3/2013 9:53:37 AM
12345678910...